APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologic Medications for Psoriasis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologic Medications for Psoriasis Industry Growth and Trends Forecast to 2032

Report ID 173970670127 December 2025112 pages

Choose your research edition.

Industry ResearchBiologic Medications for Psoriasis Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Medications for Psoriasis Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biologic Medications for Psoriasis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Medications for Psoriasis Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Medications for Psoriasis Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Biologic Medications for Psoriasis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologic Medications for Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologic Medications for Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Medications for Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologic Medications for Psoriasis include AbbVie Biotechnology, Amgen, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly, Janssen Biotech, Kyowa Kirin, LEO Pharma and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologic Medications for Psoriasis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologic Medications for Psoriasis market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologic Medications for Psoriasis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologic Medications for Psoriasis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biologic Medications for Psoriasis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologic Medications for Psoriasis Market by Company

AbbVie Biotechnology

Amgen

Boehringer Ingelheim Pharmaceuticals

Bristol-Myers Squibb

Eli Lilly

Janssen Biotech

Kyowa Kirin

LEO Pharma

Novartis

Ortho Dermatologics

Pfizer

Samsung Bioepis

Tiefenbacher Pharmaceuticals

UCB

Dalian Yawei Pharmaceutical

Hanwha Chemical

China Medical System

Qilu Pharmaceutical

Biologic Medications for Psoriasis Segment by Type

Interleukin Inhibitors

Tyrosine Kinase Inhibitors

Phosphodiesterase Inhibitors

TNF-α Inhibitors

Other

Biologic Medications for Psoriasis Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Biologic Medications for Psoriasis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Medications for Psoriasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Medications for Psoriasis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Medications for Psoriasis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biologic Medications for Psoriasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biologic Medications for Psoriasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Interleukin Inhibitors Table 2. Major Company of Tyrosine Kinase Inhibitors Table 3. Major Company of Phosphodiesterase Inhibitors Table 4. Major Company of TNF-α Inhibitors Table 5. Major Company of Other Table 6. Global Biologic Medications for Psoriasis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biologic Medications for Psoriasis Sales by Type (2021-2026) & (K Units) Table 8. Global Biologic Medications for Psoriasis Sales Market Share in Volume by Type (2021-2026) Table 9. Global Biologic Medications for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 10. Global Biologic Medications for Psoriasis Sales Market Share in Value by Type (2021-2026) Table 11. Global Biologic Medications for Psoriasis Price by Type (2021-2026) & (US$/Unit) Table 12. Global Biologic Medications for Psoriasis Sales by Type (2027-2032) & (K Units) Table 13. Global Biologic Medications for Psoriasis Sales Market Share in Volume by Type (2027-2032) Table 14. Global Biologic Medications for Psoriasis Sales by Type (2027-2032) & (US$ Million) Table 15. Global Biologic Medications for Psoriasis Sales Market Share in Value by Type (2027-2032) Table 16. Global Biologic Medications for Psoriasis Price by Type (2027-2032) & (US$/Unit) Table 17. North America Biologic Medications for Psoriasis Sales by Type (2021-2026) & (K Units) Table 18. North America Biologic Medications for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Biologic Medications for Psoriasis Sales by Type (2021-2026) & (K Units) Table 20. Europe Biologic Medications for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Biologic Medications for Psoriasis Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Biologic Medications for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Biologic Medications for Psoriasis Sales by Type (2021-2026) & (K Units) Table 24. Latin America Biologic Medications for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Biologic Medications for Psoriasis Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Biologic Medications for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 27. Biologic Medications for Psoriasis Industry Trends Table 28. Biologic Medications for Psoriasis Industry Drivers Table 29. Biologic Medications for Psoriasis Industry Opportunities and Challenges Table 30. Biologic Medications for Psoriasis Industry Restraints Table 31. Global Biologic Medications for Psoriasis Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Biologic Medications for Psoriasis Revenue Market Share by Company (2021-2026) Table 33. Global Biologic Medications for Psoriasis Sales by Company (2021-2026) & (K Units) Table 34. Global Biologic Medications for Psoriasis Sales Share by Company (2021-2026) Table 35. Global Biologic Medications for Psoriasis Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Biologic Medications for Psoriasis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Biologic Medications for Psoriasis Major Company Production Sites and Headquarters Table 38. Global Biologic Medications for Psoriasis Company, Product Type & Application Table 39. Global Biologic Medications for Psoriasis Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Biologic Medications for Psoriasis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Biologic Medications for Psoriasis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Biologic Medications for Psoriasis Sales by Region (2021-2026) & (K Units) Table 44. Global Biologic Medications for Psoriasis Sales Market Share in Volume by Region (2021-2026) Table 45. Global Biologic Medications for Psoriasis Sales by Region (2021-2026) & (US$ Million) Table 46. Global Biologic Medications for Psoriasis Sales Market Share in Value by Region (2021-2026) Table 47. Global Biologic Medications for Psoriasis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Biologic Medications for Psoriasis Sales by Region (2027-2032) & (K Units) Table 49. Global Biologic Medications for Psoriasis Sales Market Share in Volume by Region (2027-2032) Table 50. Global Biologic Medications for Psoriasis Sales by Region (2027-2032) & (US$ Million) Table 51. Global Biologic Medications for Psoriasis Sales Market Share in Value by Region (2027-2032) Table 52. Global Biologic Medications for Psoriasis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Biologic Medications for Psoriasis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Biologic Medications for Psoriasis Sales by Application (2021-2026) & (K Units) Table 55. Global Biologic Medications for Psoriasis Sales Market Share in Volume by Application (2021-2026) Table 56. Global Biologic Medications for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 57. Global Biologic Medications for Psoriasis Sales Market Share in Value by Application (2021-2026) Table 58. Global Biologic Medications for Psoriasis Price by Application (2021-2026) & (US$/Unit) Table 59. Global Biologic Medications for Psoriasis Sales by Application (2027-2032) & (K Units) Table 60. Global Biologic Medications for Psoriasis Sales Market Share in Volume by Application (2027-2032) Table 61. Global Biologic Medications for Psoriasis Sales by Application (2027-2032) & (US$ Million) Table 62. Global Biologic Medications for Psoriasis Sales Market Share in Value by Application (2027-2032) Table 63. Global Biologic Medications for Psoriasis Price by Application (2027-2032) & (US$/Unit) Table 64. North America Biologic Medications for Psoriasis Sales by Application (2021-2026) & (K Units) Table 65. North America Biologic Medications for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Biologic Medications for Psoriasis Sales by Application (2021-2026) & (K Units) Table 67. Europe Biologic Medications for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Biologic Medications for Psoriasis Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Biologic Medications for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Biologic Medications for Psoriasis Sales by Application (2021-2026) & (K Units) Table 71. Latin America Biologic Medications for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Biologic Medications for Psoriasis Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Biologic Medications for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 74. AbbVie Biotechnology Company Information Table 75. AbbVie Biotechnology Business Overview Table 76. AbbVie Biotechnology Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. AbbVie Biotechnology Biologic Medications for Psoriasis Product Portfolio Table 78. AbbVie Biotechnology Recent Development Table 79. Amgen Company Information Table 80. Amgen Business Overview Table 81. Amgen Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Amgen Biologic Medications for Psoriasis Product Portfolio Table 83. Amgen Recent Development Table 84. Boehringer Ingelheim Pharmaceuticals Company Information Table 85. Boehringer Ingelheim Pharmaceuticals Business Overview Table 86. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Portfolio Table 88. Boehringer Ingelheim Pharmaceuticals Recent Development Table 89. Bristol-Myers Squibb Company Information Table 90. Bristol-Myers Squibb Business Overview Table 91. Bristol-Myers Squibb Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bristol-Myers Squibb Biologic Medications for Psoriasis Product Portfolio Table 93. Bristol-Myers Squibb Recent Development Table 94. Eli Lilly Company Information Table 95. Eli Lilly Business Overview Table 96. Eli Lilly Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Eli Lilly Biologic Medications for Psoriasis Product Portfolio Table 98. Eli Lilly Recent Development Table 99. Janssen Biotech Company Information Table 100. Janssen Biotech Business Overview Table 101. Janssen Biotech Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Janssen Biotech Biologic Medications for Psoriasis Product Portfolio Table 103. Janssen Biotech Recent Development Table 104. Kyowa Kirin Company Information Table 105. Kyowa Kirin Business Overview Table 106. Kyowa Kirin Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Kyowa Kirin Biologic Medications for Psoriasis Product Portfolio Table 108. Kyowa Kirin Recent Development Table 109. LEO Pharma Company Information Table 110. LEO Pharma Business Overview Table 111. LEO Pharma Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. LEO Pharma Biologic Medications for Psoriasis Product Portfolio Table 113. LEO Pharma Recent Development Table 114. Novartis Company Information Table 115. Novartis Business Overview Table 116. Novartis Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Novartis Biologic Medications for Psoriasis Product Portfolio Table 118. Novartis Recent Development Table 119. Ortho Dermatologics Company Information Table 120. Ortho Dermatologics Business Overview Table 121. Ortho Dermatologics Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Ortho Dermatologics Biologic Medications for Psoriasis Product Portfolio Table 123. Ortho Dermatologics Recent Development Table 124. Pfizer Company Information Table 125. Pfizer Business Overview Table 126. Pfizer Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Pfizer Biologic Medications for Psoriasis Product Portfolio Table 128. Pfizer Recent Development Table 129. Samsung Bioepis Company Information Table 130. Samsung Bioepis Business Overview Table 131. Samsung Bioepis Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Samsung Bioepis Biologic Medications for Psoriasis Product Portfolio Table 133. Samsung Bioepis Recent Development Table 134. Tiefenbacher Pharmaceuticals Company Information Table 135. Tiefenbacher Pharmaceuticals Business Overview Table 136. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Portfolio Table 138. Tiefenbacher Pharmaceuticals Recent Development Table 139. UCB Company Information Table 140. UCB Business Overview Table 141. UCB Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. UCB Biologic Medications for Psoriasis Product Portfolio Table 143. UCB Recent Development Table 144. Dalian Yawei Pharmaceutical Company Information Table 145. Dalian Yawei Pharmaceutical Business Overview Table 146. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Portfolio Table 148. Dalian Yawei Pharmaceutical Recent Development Table 149. Hanwha Chemical Company Information Table 150. Hanwha Chemical Business Overview Table 151. Hanwha Chemical Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Hanwha Chemical Biologic Medications for Psoriasis Product Portfolio Table 153. Hanwha Chemical Recent Development Table 154. China Medical System Company Information Table 155. China Medical System Business Overview Table 156. China Medical System Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. China Medical System Biologic Medications for Psoriasis Product Portfolio Table 158. China Medical System Recent Development Table 159. Qilu Pharmaceutical Company Information Table 160. Qilu Pharmaceutical Business Overview Table 161. Qilu Pharmaceutical Biologic Medications for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Qilu Pharmaceutical Biologic Medications for Psoriasis Product Portfolio Table 163. Qilu Pharmaceutical Recent Development Table 164. North America Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. North America Biologic Medications for Psoriasis Sales by Country (2021-2026) & (K Units) Table 166. North America Biologic Medications for Psoriasis Sales Market Share by Country (2021-2026) Table 167. North America Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 168. North America Biologic Medications for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 169. North America Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. North America Biologic Medications for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 171. North America Biologic Medications for Psoriasis Market Share by Country (2021-2026) Table 172. North America Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. North America Biologic Medications for Psoriasis Market Share Forecast by Country (2027-2032) Table 174. Europe Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Europe Biologic Medications for Psoriasis Sales by Country (2021-2026) & (K Units) Table 176. Europe Biologic Medications for Psoriasis Sales Market Share by Country (2021-2026) Table 177. Europe Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 178. Europe Biologic Medications for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 179. Europe Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Europe Biologic Medications for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 181. Europe Biologic Medications for Psoriasis Market Share by Country (2021-2026) Table 182. Europe Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Europe Biologic Medications for Psoriasis Market Share Forecast by Country (2027-2032) Table 184. Asia-Pacific Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Asia-Pacific Biologic Medications for Psoriasis Sales by Country (2021-2026) & (K Units) Table 186. Asia-Pacific Biologic Medications for Psoriasis Sales Market Share by Country (2021-2026) Table 187. Asia-Pacific Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 188. Asia-Pacific Biologic Medications for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 189. Asia-Pacific Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Asia-Pacific Biologic Medications for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 191. Asia-Pacific Biologic Medications for Psoriasis Market Share by Country (2021-2026) Table 192. Asia-Pacific Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Asia-Pacific Biologic Medications for Psoriasis Market Share Forecast by Country (2027-2032) Table 194. Latin America Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 195. Latin America Biologic Medications for Psoriasis Sales by Country (2021-2026) & (K Units) Table 196. Latin America Biologic Medications for Psoriasis Sales Market Share by Country (2021-2026) Table 197. Latin America Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 198. Latin America Biologic Medications for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 199. Latin America Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Latin America Biologic Medications for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 201. Latin America Biologic Medications for Psoriasis Market Share by Country (2021-2026) Table 202. Latin America Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Latin America Biologic Medications for Psoriasis Market Share Forecast by Country (2027-2032) Table 204. Middle East and Africa Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 205. Middle East and Africa Biologic Medications for Psoriasis Sales by Country (2021-2026) & (K Units) Table 206. Middle East and Africa Biologic Medications for Psoriasis Sales Market Share by Country (2021-2026) Table 207. Middle East and Africa Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 208. Middle East and Africa Biologic Medications for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 209. Middle East and Africa Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Middle East and Africa Biologic Medications for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 211. Middle East and Africa Biologic Medications for Psoriasis Market Share by Country (2021-2026) Table 212. Middle East and Africa Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Middle East and Africa Biologic Medications for Psoriasis Market Share Forecast by Country (2027-2032) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Biologic Medications for Psoriasis Distributors List Table 217. Biologic Medications for Psoriasis Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Biologic Medications for Psoriasis Image Figure 2. Global Biologic Medications for Psoriasis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Medications for Psoriasis Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologic Medications for Psoriasis Sales (2021-2032) & (K Units) Figure 5. Interleukin Inhibitors Image Figure 6. Global Interleukin Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tyrosine Kinase Inhibitors Image Figure 8. Global Tyrosine Kinase Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Phosphodiesterase Inhibitors Image Figure 10. Global Phosphodiesterase Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 11. TNF-α Inhibitors Image Figure 12. Global TNF-α Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Biologic Medications for Psoriasis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Biologic Medications for Psoriasis Market Share by Type 2025 VS 2032 Figure 17. North America Biologic Medications for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 18. North America Biologic Medications for Psoriasis Sales Market Share in Value by Type in 2025 Figure 19. Europe Biologic Medications for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 20. Europe Biologic Medications for Psoriasis Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Biologic Medications for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Biologic Medications for Psoriasis Sales Market Share in Value by Type in 2025 Figure 23. Latin America Biologic Medications for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Biologic Medications for Psoriasis Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Biologic Medications for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Biologic Medications for Psoriasis Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Biologic Medications for Psoriasis Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital and Clinic Image Figure 32. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Biologic Medications for Psoriasis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Biologic Medications for Psoriasis Market Share by Application 2025 VS 2032 Figure 37. North America Biologic Medications for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 38. North America Biologic Medications for Psoriasis Sales Market Share in Value by Application in 2025 Figure 39. Europe Biologic Medications for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 40. Europe Biologic Medications for Psoriasis Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Biologic Medications for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Biologic Medications for Psoriasis Sales Market Share in Value by Application in 2025 Figure 43. Latin America Biologic Medications for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Biologic Medications for Psoriasis Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Biologic Medications for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Biologic Medications for Psoriasis Sales Market Share in Value by Application in 2025 Figure 47. North America Biologic Medications for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Biologic Medications for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Biologic Medications for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Biologic Medications for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Biologic Medications for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Biologic Medications for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Biologic Medications for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Biologic Medications for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Biologic Medications for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Biologic Medications for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Biologic Medications for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Biologic Medications for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Biologic Medications for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Biologic Medications for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Biologic Medications for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Biologic Medications for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Biologic Medications for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Biologic Medications for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Biologic Medications for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Biologic Medications for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Biologic Medications for Psoriasis Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Biologic Medications for Psoriasis Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Interleukin Inhibitors
  • Tyrosine Kinase Inhibitors
  • Phosphodiesterase Inhibitors
  • TNF-α Inhibitors
  • Other
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • AbbVie Biotechnology
  • Amgen
  • Boehringer Ingelheim Pharmaceuticals
  • Bristol-Myers Squibb
  • Eli Lilly
  • Janssen Biotech
  • Kyowa Kirin
  • LEO Pharma
  • Novartis
  • Ortho Dermatologics
  • Pfizer
  • Samsung Bioepis
  • Tiefenbacher Pharmaceuticals
  • UCB
  • Dalian Yawei Pharmaceutical
  • Hanwha Chemical
  • China Medical System
  • Qilu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biologic Medications for Psoriasis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biologic Medications for Psoriasis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biologic Medications for Psoriasis Market by Type
  6. 1.3.1 Interleukin Inhibitors
  7. 1.3.2 Tyrosine Kinase Inhibitors
  8. 1.3.3 Phosphodiesterase Inhibitors
  9. 1.3.4 TNF-α Inhibitors
  10. 1.3.5 Other
  11. 1.4 Global Biologic Medications for Psoriasis Market Size by Type
  12. 1.4.1 Global Biologic Medications for Psoriasis Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Biologic Medications for Psoriasis Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Biologic Medications for Psoriasis Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Biologic Medications for Psoriasis Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Biologic Medications for Psoriasis Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Biologic Medications for Psoriasis Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Biologic Medications for Psoriasis Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Biologic Medications for Psoriasis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biologic Medications for Psoriasis Industry Trends
  2. 2.2 Biologic Medications for Psoriasis Industry Drivers
  3. 2.3 Biologic Medications for Psoriasis Industry Opportunities and Challenges
  4. 2.4 Biologic Medications for Psoriasis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biologic Medications for Psoriasis Revenue (2021-2026)
  2. 3.2 Global Top Players by Biologic Medications for Psoriasis Sales (2021-2026)
  3. 3.3 Global Top Players by Biologic Medications for Psoriasis Price (2021-2026)
  4. 3.4 Global Biologic Medications for Psoriasis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biologic Medications for Psoriasis Major Company Production Sites & Headquarters
  6. 3.6 Global Biologic Medications for Psoriasis Company, Product Type & Application
  7. 3.7 Global Biologic Medications for Psoriasis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biologic Medications for Psoriasis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biologic Medications for Psoriasis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biologic Medications for Psoriasis Tier 1, Tier 2, and Tier 3
4 Biologic Medications for Psoriasis Regional Status and Outlook
  1. 4.1 Global Biologic Medications for Psoriasis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biologic Medications for Psoriasis Historic Market Size by Region
  3. 4.2.1 Global Biologic Medications for Psoriasis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biologic Medications for Psoriasis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biologic Medications for Psoriasis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biologic Medications for Psoriasis Forecasted Market Size by Region
  7. 4.3.1 Global Biologic Medications for Psoriasis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biologic Medications for Psoriasis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biologic Medications for Psoriasis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biologic Medications for Psoriasis by Application
  1. 5.1 Biologic Medications for Psoriasis Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Biologic Medications for Psoriasis Market Size by Application
  6. 5.2.1 Global Biologic Medications for Psoriasis Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Biologic Medications for Psoriasis Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Biologic Medications for Psoriasis Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Biologic Medications for Psoriasis Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Biologic Medications for Psoriasis Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Biologic Medications for Psoriasis Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Biologic Medications for Psoriasis Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Biologic Medications for Psoriasis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie Biotechnology
  2. 6.1.1 AbbVie Biotechnology Company Information
  3. 6.1.2 AbbVie Biotechnology Business Overview
  4. 6.1.3 AbbVie Biotechnology Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Biotechnology Biologic Medications for Psoriasis Product Portfolio
  6. 6.1.5 AbbVie Biotechnology Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Biologic Medications for Psoriasis Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 Boehringer Ingelheim Pharmaceuticals
  14. 6.3.1 Boehringer Ingelheim Pharmaceuticals Company Information
  15. 6.3.2 Boehringer Ingelheim Pharmaceuticals Business Overview
  16. 6.3.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Biologic Medications for Psoriasis Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Biologic Medications for Psoriasis Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Janssen Biotech
  32. 6.6.1 Janssen Biotech Company Information
  33. 6.6.2 Janssen Biotech Business Overview
  34. 6.6.3 Janssen Biotech Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Janssen Biotech Biologic Medications for Psoriasis Product Portfolio
  36. 6.6.5 Janssen Biotech Recent Developments
  37. 6.7 Kyowa Kirin
  38. 6.7.1 Kyowa Kirin Company Information
  39. 6.7.2 Kyowa Kirin Business Overview
  40. 6.7.3 Kyowa Kirin Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kyowa Kirin Biologic Medications for Psoriasis Product Portfolio
  42. 6.7.5 Kyowa Kirin Recent Developments
  43. 6.8 LEO Pharma
  44. 6.8.1 LEO Pharma Company Information
  45. 6.8.2 LEO Pharma Business Overview
  46. 6.8.3 LEO Pharma Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 LEO Pharma Biologic Medications for Psoriasis Product Portfolio
  48. 6.8.5 LEO Pharma Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Biologic Medications for Psoriasis Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Ortho Dermatologics
  56. 6.10.1 Ortho Dermatologics Company Information
  57. 6.10.2 Ortho Dermatologics Business Overview
  58. 6.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ortho Dermatologics Biologic Medications for Psoriasis Product Portfolio
  60. 6.10.5 Ortho Dermatologics Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Biologic Medications for Psoriasis Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Samsung Bioepis
  68. 6.12.1 Samsung Bioepis Company Information
  69. 6.12.2 Samsung Bioepis Business Overview
  70. 6.12.3 Samsung Bioepis Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Samsung Bioepis Biologic Medications for Psoriasis Product Portfolio
  72. 6.12.5 Samsung Bioepis Recent Developments
  73. 6.13 Tiefenbacher Pharmaceuticals
  74. 6.13.1 Tiefenbacher Pharmaceuticals Company Information
  75. 6.13.2 Tiefenbacher Pharmaceuticals Business Overview
  76. 6.13.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Portfolio
  78. 6.13.5 Tiefenbacher Pharmaceuticals Recent Developments
  79. 6.14 UCB
  80. 6.14.1 UCB Company Information
  81. 6.14.2 UCB Business Overview
  82. 6.14.3 UCB Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 UCB Biologic Medications for Psoriasis Product Portfolio
  84. 6.14.5 UCB Recent Developments
  85. 6.15 Dalian Yawei Pharmaceutical
  86. 6.15.1 Dalian Yawei Pharmaceutical Company Information
  87. 6.15.2 Dalian Yawei Pharmaceutical Business Overview
  88. 6.15.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Portfolio
  90. 6.15.5 Dalian Yawei Pharmaceutical Recent Developments
  91. 6.16 Hanwha Chemical
  92. 6.16.1 Hanwha Chemical Company Information
  93. 6.16.2 Hanwha Chemical Business Overview
  94. 6.16.3 Hanwha Chemical Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Hanwha Chemical Biologic Medications for Psoriasis Product Portfolio
  96. 6.16.5 Hanwha Chemical Recent Developments
  97. 6.17 China Medical System
  98. 6.17.1 China Medical System Company Information
  99. 6.17.2 China Medical System Business Overview
  100. 6.17.3 China Medical System Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 China Medical System Biologic Medications for Psoriasis Product Portfolio
  102. 6.17.5 China Medical System Recent Developments
  103. 6.18 Qilu Pharmaceutical
  104. 6.18.1 Qilu Pharmaceutical Company Information
  105. 6.18.2 Qilu Pharmaceutical Business Overview
  106. 6.18.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Qilu Pharmaceutical Biologic Medications for Psoriasis Product Portfolio
  108. 6.18.5 Qilu Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Biologic Medications for Psoriasis Sales by Country
  2. 7.1.1 North America Biologic Medications for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biologic Medications for Psoriasis Sales by Country (2021-2026)
  4. 7.1.3 North America Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biologic Medications for Psoriasis Market Size by Country
  6. 7.2.1 North America Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biologic Medications for Psoriasis Market Size by Country (2021-2026)
  8. 7.2.3 North America Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biologic Medications for Psoriasis Sales by Country
  2. 8.1.1 Europe Biologic Medications for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biologic Medications for Psoriasis Sales by Country (2021-2026)
  4. 8.1.3 Europe Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biologic Medications for Psoriasis Market Size by Country
  6. 8.2.1 Europe Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biologic Medications for Psoriasis Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biologic Medications for Psoriasis Sales by Country
  2. 9.1.1 Asia-Pacific Biologic Medications for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biologic Medications for Psoriasis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biologic Medications for Psoriasis Market Size by Country
  6. 9.2.1 Asia-Pacific Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biologic Medications for Psoriasis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biologic Medications for Psoriasis Sales by Country
  2. 10.1.1 South America Biologic Medications for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biologic Medications for Psoriasis Sales by Country (2021-2026)
  4. 10.1.3 South America Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biologic Medications for Psoriasis Market Size by Country
  6. 10.2.1 South America Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biologic Medications for Psoriasis Market Size by Country (2021-2026)
  8. 10.2.3 South America Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biologic Medications for Psoriasis Sales by Country
  2. 11.1.1 Middle East and Africa Biologic Medications for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biologic Medications for Psoriasis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biologic Medications for Psoriasis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biologic Medications for Psoriasis Market Size by Country
  6. 11.2.1 Middle East and Africa Biologic Medications for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biologic Medications for Psoriasis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biologic Medications for Psoriasis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biologic Medications for Psoriasis Value Chain Analysis
  2. 12.1.1 Biologic Medications for Psoriasis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biologic Medications for Psoriasis Production Mode & Process
  7. 12.2 Biologic Medications for Psoriasis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biologic Medications for Psoriasis Distributors
  10. 12.2.3 Biologic Medications for Psoriasis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst